The Evolving Role of Esmolol in Management of Pre-Hospital Refractory Ventricular Fibrillation; a Scoping Review
Introduction: Few studies have described their experience using esmolol, an ultra-short acting β-adrenergic antagonist, in the emergency department (ED) as a feasible adjuvant therapy for the treatment of refractory ventricular fibrillation/pulseless ventricular tachycardia (VF/pVT) out-of-hospital...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Shahid Beheshti University of Medical Sciences
2020-03-01
|
Series: | Archives of Academic Emergency Medicine |
Subjects: | |
Online Access: | https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/553 |